Evaluation of Serum Kallistatin Levels in Women with Preeclampsia and its Role in Assessing Preeclampsia Severity
Background: Preeclampsia (PE) is a hypertension condition that often manifests after 20 weeks of gestation. It is regarded as a leading cause of death among mothers and babies globally. Aim: To evaluate how serum kallistatin affects PE severity. Patients and Methods: A case–control study that includ...
Saved in:
Main Authors: | Rangeen Badri Mahdi, Esraa Hameed Al-Maini |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Mustansiriya Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/mj.mj_5_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil Gelatinase-Associated Lipocalin Levels in Early and Late Onset Preeclampsia
by: Onur Guralp, et al.
Published: (2020-12-01) -
The Effects of Preeclampsia Severity and Thrombocytopenia on the Prognosis of Hypertensive Pregnant Women
by: Emre Beşe, et al.
Published: (2013-04-01) -
Assessment of Renal Function in Women with Preeclampsia by Measuring of Serum Cystatin C Level
by: Marwa Basim Yarmurad, et al.
Published: (2024-12-01) -
Current preeclampsia prediction model and biomarker
by: Anak Agung Ngurah Jaya Kusuma
Published: (2024-11-01) -
Elevated Liver Function Tests as Predictors of Severe Maternal Outcomes in Women with Preeclampsia
by: Sadia Chaudhary, et al.
Published: (2025-01-01)